Navigating the Landscape of Immunogenicity Assay Development for Enhanced Biologics Evaluation In the realm of biotherapeutics, the risk of undesired immune responses poses a significant
Navigating the Landscape of Immunogenicity Assay Development for Enhanced Biologics Evaluation In the realm of biotherapeutics, the risk of undesired immune responses poses a significant